The myocardial remodeling at ischemic chronic heart failure: the features of Ivabradine influence in experimental model

Authors

  • S. V. Fedorov Ivano-Frankivsk National Medical University, Ukraine,
  • I. V. Kozlova Ivano-Frankivsk National Medical University, Ukraine,
  • G. P. Gamorak Ivano-Frankivsk National Medical University, Ukraine,
  • A. S. Geraschenko Ivano-Frankivsk National Medical University, Ukraine,

DOI:

https://doi.org/10.14739/2310-1210.2016.6.85500

Keywords:

chronic heart failure, myocardial remodeling, experimental model, ivabradine

Abstract

Aim. Experimental study of Ivabradine influence on myocardial remodeling in patients with ischemic chronic heart failure.

Material and Methods. The ischemic model of heart failure (HF) was modeled in 30 mature rats by isoproterenol injection. All animals were divided into 3 groups (10 each): I – control; II – with model of HF; III – with HF model and Ivabradine usage. For calculation of metric characteristics of the cardiomyocytes UTHSCSA Image Tool® for Windows® (version 2.00) program equipment in interactive regime was used. Morphometric analysis was made by point-based calculation method with 72-network. Statistical analysis was made by standard program equipment “Statistica for Windows12.0” (StatSoft,Tulsa,OK,USA).

Results. In experimental animals with model of ischemic HF the substantial hypertrophy of cardiomyocytes was observed. This process was characterized by increase in cardiomyocytes cross-sectional area, cross-sectional area of nuclei, decrease of nucleus-to-cytoplasm ratio and some discoordination of this parameter. In case of Ivabradine prescription we have noted reduction in myocardial hypertrophy processes with the following sings: decrease in mean cardiomyocytes cross-sectional area in 1.31 times (p<0,05), and mean cross-sectional area of nuclei – in 1.41 times (p<0,05).

Conclusions. 1. In case of ischemic heart failure the substantial hypertrophy of cardiomyocytes with increase in mean parameters of their nuclei volume and nucleus-to-cytoplasm ratio disturbances were observed.

2. Ivabradine caused a mild regression of myocardial remodeling, as evidenced by a decrease in the degree of cardiomyocytes and their nuclei hypertrophy, severity of parenchyma dystrophy and fibrosis of heart muscle. 

References

Filippatos, G., & Parissis, J. T. (2011) Heart failure diagnosis and prognosis in the elderly: the proof of the pudding is in the eating. Eur. J. Heart Fail., 13, 467–471. doi:10.1093/eurjhf/hfr036.

Van Riet, E. E. S., Hoes, A. W., Limburg, A., Landman, M. A. J., van der Hoeven, H., & Rutten, F. H. (2014) Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur. J. Heart Fail., 16, 772–777. doi: 10.1002/ejhf.110.

(1991) The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N. Engl. J. Med., 325, 293–302. doi: 10.1056/NEJM199108013250501.

Cowie, M. (Ed) (2013). Essentials of heart failure. John Willey and Sons, Ltd.

Fox, K., Cowie, M., Wood, D., Coats, A. J., Gibbs, J. S., Underwood, S. R., et al. (2001) Coronary artery disease as the cause of incident of heart failure in the population. Eur. Heart J., 22, 228–236. doi: 10.1053/euhj.2000.2289.

The Guide for Care and Use of Laboratory Animals of the National Institutes of Health. (2011). Washington: NAS.

Zbinden, G., & Bagdon, R. E. (1963) Isoproterenol-induced heart necrosis, an experimental model for the study of angina pectoris and myocardial infarct. Reviews of Canadian Biology, 22, 257–263.

Avtandilov, G. G. (1990). Medicinskaya morfometriya [Medical morphometry]. Moscow: Medicine. [in Russian].

Reil, J.-C., Hohl, M., Reil, G.-H., Granzier, H. L., Kratz, M. T., Kazakov, A., et al. (2013) Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction. European Heart Journal, 34(36), 2839–2849. doi: 10.1093/eurheartj/ehs218.

Kim, B. H., Cho, K., Kim, S. M., Kim, N., Han, J., Kim, J. Y., & Kim, I. J. (2013) Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat. Heart and Vessels, 28, 524–535. doi: 10.1007/s00380-012-0304-z.

Downloads

How to Cite

1.
Fedorov SV, Kozlova IV, Gamorak GP, Geraschenko AS. The myocardial remodeling at ischemic chronic heart failure: the features of Ivabradine influence in experimental model. Zaporozhye medical journal [Internet]. 2016Dec.8 [cited 2024Apr.16];18(6). Available from: http://zmj.zsmu.edu.ua/article/view/85500

Issue

No. 6 (2016): Zaporozhye medical journal

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)